The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion ...

A new study finds a possible association between GLP-1 drugs like semaglutide and chronic cough, though the authors are ...

Okava Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new GLP-1 clinical weight loss study ...

The World Health Organization on Monday recommended GLP-1 drugs as a tool to manage obesity in adults, marking a shift in the ...

Novo Nordisk says it still thinks GLP-1 drugs could be a promising treatment for Alzheimer’s, despite two disappointing ...

The World Health Organization conditionally recommended GLP-1 drugs for obesity. A physician breaks down what you need to ...

Globally, more than 1 billion people currently live with obesity.

CLEVELAND, Ohio — One in eight adults in the United States are now using Ozempic, Wegovy or similar GLP-1 drugs, according to ...

A California company, Okava Pharmaceuticals, has launched a clinical trial testing a GLP-1–based weight loss treatment in 50 ...

November 25, 2025 – PRESSADVANTAGE – LifeRx.md announced that it has implemented reduced pricing for its personalized GLP-1 ...

GLP-1 weight loss drugs are now being tested in pets. San Francisco-based Okawa Pharmaceuticals has launched a clinical trial ...

The World Health Organization is now recommending GLP-1 drugs as a tool to manage obesity in adults. The guidance, which says ...